BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31068430)

  • 1. A Noncanonical Basic Motif of Epstein-Barr Virus ZEBRA Protein Facilitates Recognition of Methylated DNA, High-Affinity DNA Binding, and Lytic Activation.
    Weber E; Buzovetsky O; Heston L; Yu KP; Knecht KM; El-Guindy A; Miller G; Xiong Y
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication.
    Lyons DE; Yu KP; Vander Heiden JA; Heston L; Dittmer DP; El-Guindy A; Miller G
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of DNA methylation-dependent site selectivity of the Epstein-Barr virus lytic switch protein ZEBRA/Zta/BZLF1.
    Bernaudat F; Gustems M; Günther J; Oliva MF; Buschle A; Göbel C; Pagniez P; Lupo J; Signor L; Müller CW; Morand P; Sattler M; Hammerschmidt W; Petosa C
    Nucleic Acids Res; 2022 Jan; 50(1):490-511. PubMed ID: 34893887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.
    Wille CK; Nawandar DM; Panfil AR; Ko MM; Hagemeier SR; Kenney SC
    J Virol; 2013 Jan; 87(2):935-50. PubMed ID: 23135711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency.
    Francis AL; Gradoville L; Miller G
    J Virol; 1997 Apr; 71(4):3054-61. PubMed ID: 9060666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.
    Woellmer A; Arteaga-Salas JM; Hammerschmidt W
    PLoS Pathog; 2012 Sep; 8(9):e1002902. PubMed ID: 22969425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nascent Transcriptomics Reveal Cellular Prolytic Factors Upregulated Upstream of the Latent-to-Lytic Switch Protein of Epstein-Barr Virus.
    Frey TR; Brathwaite J; Li X; Burgula S; Akinyemi IA; Agarwal S; Burton EM; Ljungman M; McIntosh MT; Bhaduri-McIntosh S
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acids in the basic domain of Epstein-Barr virus ZEBRA protein play distinct roles in DNA binding, activation of early lytic gene expression, and promotion of viral DNA replication.
    Heston L; El-Guindy A; Countryman J; Dela Cruz C; Delecluse HJ; Miller G
    J Virol; 2006 Sep; 80(18):9115-33. PubMed ID: 16940523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epstein-Barr virus ZEBRA protein activates transcription from the early lytic F promoter by binding to a promoter-proximal AP-1-like site.
    Zetterberg H; Jansson A; Rymo L; Chen F; Karlsson A; Klein G; Brodin B
    J Gen Virol; 2002 Aug; 83(Pt 8):2007-2014. PubMed ID: 12124465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites.
    Kalla M; Göbel C; Hammerschmidt W
    J Virol; 2012 Jan; 86(1):447-58. PubMed ID: 22031942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latency of Epstein-Barr virus is disrupted by gain-of-function mutant cellular AP-1 proteins that preferentially bind methylated DNA.
    Yu KP; Heston L; Park R; Ding Z; Wang'ondu R; Delecluse HJ; Miller G
    Proc Natl Acad Sci U S A; 2013 May; 110(20):8176-81. PubMed ID: 23625009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrograde Regulation by the Viral Protein Kinase Epigenetically Sustains the Epstein-Barr Virus Latency-to-Lytic Switch To Augment Virus Production.
    Li X; Kozlov SV; El-Guindy A; Bhaduri-McIntosh S
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein.
    Petosa C; Morand P; Baudin F; Moulin M; Artero JB; Müller CW
    Mol Cell; 2006 Feb; 21(4):565-72. PubMed ID: 16483937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of Epstein-Barr virus ZEBRA protein at its casein kinase 2 sites mediates its ability to repress activation of a viral lytic cycle late gene by Rta.
    El-Guindy AS; Miller G
    J Virol; 2004 Jul; 78(14):7634-44. PubMed ID: 15220438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
    Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta.
    Almohammed R; Osborn K; Ramasubramanyan S; Perez-Fernandez IBN; Godfrey A; Mancini EJ; Sinclair AJ
    J Gen Virol; 2018 Jun; 99(6):805-817. PubMed ID: 29580369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG-methylation regulates a class of Epstein-Barr virus promoters.
    Bergbauer M; Kalla M; Schmeinck A; Göbel C; Rothbauer U; Eck S; Benet-Pagès A; Strom TM; Hammerschmidt W
    PLoS Pathog; 2010 Sep; 6(9):e1001114. PubMed ID: 20886097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.
    Kolman JL; Taylor N; Gradoville L; Countryman J; Miller G
    J Virol; 1996 Mar; 70(3):1493-504. PubMed ID: 8627667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation domain requirements for disruption of Epstein-Barr virus latency by ZEBRA.
    Asković S; Baumann R
    J Virol; 1997 Sep; 71(9):6547-54. PubMed ID: 9261375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA.
    Wang'ondu R; Teal S; Park R; Heston L; Delecluse H; Miller G
    PLoS One; 2015; 10(5):e0126088. PubMed ID: 25950714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.